ALK+ALCL is characterized by the expression of IL-22R1 on the lymphoma cells and occurs mainly in pediatric and young adult patients.90,91 ALK+ALCL patients generally show clinical symptoms along with an inflammatory syndrome, including high fever, lymphadenopathy, and neutrophilia. The gene discussed is ALK; the disease is Lymphadenopathy.